脐带血的临床应用及可专利性。

Turker Cavusoglu, Kubilay Dogan Kilic, Gurkan Yigitturk, Canberk Tomruk, Mehmet Turgut, Yigit Uyanikgil
{"title":"脐带血的临床应用及可专利性。","authors":"Turker Cavusoglu,&nbsp;Kubilay Dogan Kilic,&nbsp;Gurkan Yigitturk,&nbsp;Canberk Tomruk,&nbsp;Mehmet Turgut,&nbsp;Yigit Uyanikgil","doi":"10.2174/1872214812666180314121241","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The blood in the umbilical cord that provides the connection between mother and fetus during pregnancy is called cord blood. The blood of umbilical cord which is usually got rid of following birth, is a very rich stem cell source.</p><p><strong>Objective: </strong>Cord blood collection gives no harm to the mother and baby. Besides, its allogeneic and autologous usage, the most important disadvantage is that the number of cells is insufficient in adults.</p><p><strong>Conclusion: </strong>Today, it is predominantly used for therapeutic purposes for many diseases. The aim of this review is giving a detailed information about groups of stem cells in cord blood and determining the point of clinical use.</p>","PeriodicalId":89474,"journal":{"name":"Recent patents on endocrine, metabolic & immune drug discovery","volume":"11 1","pages":"13-21"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Clinical Use and Patentability of Cord Blood.\",\"authors\":\"Turker Cavusoglu,&nbsp;Kubilay Dogan Kilic,&nbsp;Gurkan Yigitturk,&nbsp;Canberk Tomruk,&nbsp;Mehmet Turgut,&nbsp;Yigit Uyanikgil\",\"doi\":\"10.2174/1872214812666180314121241\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The blood in the umbilical cord that provides the connection between mother and fetus during pregnancy is called cord blood. The blood of umbilical cord which is usually got rid of following birth, is a very rich stem cell source.</p><p><strong>Objective: </strong>Cord blood collection gives no harm to the mother and baby. Besides, its allogeneic and autologous usage, the most important disadvantage is that the number of cells is insufficient in adults.</p><p><strong>Conclusion: </strong>Today, it is predominantly used for therapeutic purposes for many diseases. The aim of this review is giving a detailed information about groups of stem cells in cord blood and determining the point of clinical use.</p>\",\"PeriodicalId\":89474,\"journal\":{\"name\":\"Recent patents on endocrine, metabolic & immune drug discovery\",\"volume\":\"11 1\",\"pages\":\"13-21\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Recent patents on endocrine, metabolic & immune drug discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1872214812666180314121241\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent patents on endocrine, metabolic & immune drug discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1872214812666180314121241","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

背景:在怀孕期间为母亲和胎儿提供连接的脐带血被称为脐带血。脐带血是一种非常丰富的干细胞来源,通常在出生后被清除。目的:脐带血采集对母婴无危害。此外,它的异体和自体使用,最大的缺点是在成人中细胞数量不足。结论:今天,它主要用于治疗许多疾病。这篇综述的目的是提供关于脐带血干细胞群的详细信息,并确定临床使用的要点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Clinical Use and Patentability of Cord Blood.

Background: The blood in the umbilical cord that provides the connection between mother and fetus during pregnancy is called cord blood. The blood of umbilical cord which is usually got rid of following birth, is a very rich stem cell source.

Objective: Cord blood collection gives no harm to the mother and baby. Besides, its allogeneic and autologous usage, the most important disadvantage is that the number of cells is insufficient in adults.

Conclusion: Today, it is predominantly used for therapeutic purposes for many diseases. The aim of this review is giving a detailed information about groups of stem cells in cord blood and determining the point of clinical use.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信